Drug firm Teva bids $40bn for Mylan

Home › Drug firm Teva bids $40bn for Mylan

Generic drug company Teva proposes to buy rival Mylan in a deal that could be worth $40.1bn.

23.11	'Trust and reserve judgement' on rebrand, says Jaguar
23.11	UK wants to hire EU negotiator to 'reset' relations
23.11	Sisters build global beauty brand from a garage
23.11	Versace bag for 15: Why Christmas shoppers are choosing charity shops
23.11	'We are being robbed': Homeowners feel trapped by rising fees
22.11	'Scammers sent courier to steal 4,000'
22.11	Spain fines budget airlines including Ryanair 179m
22.11	Formulating Biphasic and Triphasic Products
Consumer Goods and Services »

je.st